Q2 2021 Holdings
Filed 2021-08-16 | 96 holdings | $10.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $3.3M | 188,719 | 30.8% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $2.2M | 192,345 | 20.3% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $2.0M | 75,732 | 18.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $1.6M | 198,245 | 15.0% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $752.0K | 99,237 | 7.0% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $737.0K | 5,599 | 6.9% |
| Spdr SER TR(XBI)Call | S&P BIOTECH | 78464A870 | $12.8K | 94,400 | 0.1% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $12.8K | 14,158 | 0.1% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $8.6K | 229,892 | 0.1% |
| Merus N V | COM | N5749R100 | $6.8K | 320,815 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $6.1K | 37,753 | 0.1% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $6.0K | 150,861 | 0.1% |
| Morphic Hldg Inc | COM | 61775R105 | $6.0K | 103,858 | 0.1% |
| Amryt Pharma PLC | SPONSORED ADS | 03217L106 | $5.5K | 456,537 | 0.1% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $5.5K | 56,626 | 0.1% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $5.5K | 827,587 | 0.1% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $5.1K | 177,433 | 0.0% |
| Research Alliance Corp II | COM CL A | 760873109 | $5.0K | 495,855 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $4.8K | 176,915 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $4.7K | 50,035 | 0.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $4.6K | 113,258 | 0.0% |
| Verastem Inc | COM | 92337C104 | $4.3K | 1,049,357 | 0.0% |
| Renalytix PLC | ADS | 75973T101 | $3.9K | 126,145 | 0.0% |
| Eloxx Pharmaceuticals Inc | COM | 29014R103 | $3.8K | 1,887,539 | 0.0% |
| Medicus Sciences Acquisition | CL A SHS | G5960S108 | $3.6K | 373,275 | 0.0% |
| Immatics N.v(IMTX) | SHS | N44445109 | $3.4K | 289,408 | 0.0% |
| Tcr2 Therapeutics Inc | COM | 87808K106 | $3.1K | 188,142 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $3.0K | 66,673 | 0.0% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $3.0K | 306,404 | 0.0% |
| Seres Therapeutics Inc(MCRB1EUR)Call | COM | 81750R102 | $2.9K | 122,700 | 0.0% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $2.9K | 9,921 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $2.8K | 538,744 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $2.7K | 15,289 | 0.0% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $2.7K | 139,305 | 0.0% |
| Social Cap Suvretta Hlds CRP | CLASS A ORD SHS | G8253U103 | $2.5K | 250,000 | 0.0% |
| Social Cap Suvretta Hlds CRP | CLASS A ORD SHS | G8253T106 | $2.5K | 250,000 | 0.0% |
| Social Cap Suvretta HLD Crpi | CLASS A ORD SHS | G8253W109 | $2.5K | 250,000 | 0.0% |
| Social Cap Suvretta Hlds CP | CLASS A ORD SHS | G8253Y105 | $2.5K | 250,000 | 0.0% |
| Helix Acquisition Corp | COM CL A | G4444C102 | $2.4K | 234,020 | 0.0% |
| Nextcure Inc | COM | 65343E108 | $2.3K | 285,498 | 0.0% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $2.2K | 242,309 | 0.0% |
| Otonomy Inc | COM | 68906L105 | $2.1K | 953,434 | 0.0% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $2.1K | 259,539 | 0.0% |
| Benitec Biopharma Inc(BNTC1EUR) | COM | 08205P100 | $2.0K | 467,256 | 0.0% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM NEW | 92840H202 | $1.9K | 615,547 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $1.9K | 75,511 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $1.8K | 34,725 | 0.0% |
| Compugen LTD(CGEN) | ORD | M25722105 | $1.7K | 209,113 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $1.7K | 82,573 | 0.0% |
| Affimed N V | COM | N01045108 | $1.7K | 202,190 | 0.0% |